HER2-mutated non-small-cell lung cancer (NSCLC) is a rare form of lung cancer where the cancer cells have a mutation that makes them grow and divide in an uncontrolled way. You can best understand ...
Hosted on MSN
Even a few mutated cells can significantly impact how blood cancers develop, study finds
"Even low numbers of mutated cancer cells profoundly affected the blood-producing system and bone homeostasis," said senior study author Patrycja Dubielecka, an associate professor at the Warren ...
News-Medical.Net on MSN
Novel drug combination overcomes resistance in aggressive KRAS-mutated lung cancer
A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and ...
Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was predictive of survival outcomes for patients with advanced KRAS G12C-mutated ...
Savolitinib and osimertinib combination significantly improves PFS in EGFR-mutated NSCLC with MET amplification compared to ...
New research reveals that certain brain tumors may originate silently within normal brain cells long before a tumor forms.
The American Cancer Society estimates that over 80,000 individuals will be diagnosed with bladder cancer this year.
Study highlights importance of cancer driver biology in translating results from lab to patients -- -- Findings validate proprietary OncoSLX ...
Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its ...
BARCELONA, Spain, Sept. 6, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) today announced new analyses from the Phase 3 MARIPOSA study showing that first-line treatment with RYBREVANT® (amivantamab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback